awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26745424-341EB59E-CE5F-4D74-99EA-8ACA54019BB7
Q26745424-341EB59E-CE5F-4D74-99EA-8ACA54019BB7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745424-341EB59E-CE5F-4D74-99EA-8ACA54019BB7
Nintedanib in NSCLC: evidence to date and place in therapy
P2860
Q26745424-341EB59E-CE5F-4D74-99EA-8ACA54019BB7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745424-341EB59E-CE5F-4D74-99EA-8ACA54019BB7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b1864400b85f223161c06a4014736d83f3295965
P2860
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer